BioSpace

Doudna’s CAR T biotech Caribou to end R&D activities, slash staff as financing freezes up

Caribou Biosciences entered the scene in 2011 and went public in 2021. Over the course of its existence, the biotech has received funding and support from a handful of Big Pharma players, including Novartis, AbbVie and Pfizer.

By BioSpace

1 min read
Doudna’s CAR T biotech Caribou to end R&D activities, slash staff as financing freezes up
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights